Point of Care Lipid Test Market Size, Share and Growth Outlook 2026: By Product Type (POC Testing Instruments / Analysers, Consumables), By Test Profile, By Application, By End User, Companies to 2034.
The global Point of Care Lipid Test Market size is forecast to increase from $850.45 Million in 2026 to $1385.44 Million in 2034 at a CAGR of 6.29% between 2026 and 2034.
The Point of Care Lipid Test market report provides detailed analysis and outlook of Point of Care Lipid Test segments including By Product Type (POC Testing Instruments / Analysers, Consumables ), By Test Profile (Total Cholesterol (TC) Testing, Triglycerides (TG) Testing, High-Density Lipoprotein (HDL) Testing, Low-Density Lipoprotein (LDL) Testing, Complete Lipid Panels (Multi-parameter Testing)), By Application (Hyperlipidemia / Dyslipidemia Screening, Cardiovascular Risk Management, Diabetes Monitoring), By End User (Hospitals, ERs, and Critical Care Units, Physician Office Laboratories (POLs) and Diagnostic Clinics, Ambulatory Care Centers, Home Care and Personal Health Monitoring) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Point-of-Care Lipid Test Industry Overview
Preventive Cardiology, Decentralized Diagnostics, and Digital Health Integration Are Driving Market Expansion
The Point-of-Care (POC) Lipid Test industry is experiencing sustained growth as healthcare systems increasingly prioritize preventive cardiovascular care, rapid clinical decision-making, and decentralized diagnostic services. Rising rates of cardiovascular disease, diabetes, and metabolic disorders are accelerating demand for testing platforms capable of delivering immediate lipid profile results during a single patient encounter. Healthcare providers are increasingly adopting point-of-care lipid testing solutions to improve risk stratification, optimize treatment monitoring, and support value-based care models. At the same time, advances in microfluidics, digital connectivity, and multi-analyte testing technologies are transforming traditional lipid testing workflows into integrated diagnostic ecosystems.
Multi-Analyte Point-of-Care Platforms Are Enhancing Clinical Decision-Making
One of the most important trends shaping the point-of-care lipid testing market is the integration of lipid analysis with broader cardiometabolic testing capabilities. Healthcare providers increasingly prefer platforms capable of simultaneously measuring multiple biomarkers to improve workflow efficiency and patient management. Reflecting this trend, Abbott Laboratories continues to expand the clinical utilization of its Afinion™ 2 Analyzer, which enables rapid assessment of lipid profiles, HbA1c, and additional biomarkers within primary care, diabetes management, and cardiovascular care settings. The ability to generate actionable results during a single patient visit supports immediate therapeutic decision-making and reinforces the growing role of decentralized diagnostic testing in chronic disease management.
Intensive Lipid Management and Digital Connectivity Are Expanding Market Opportunities
The point-of-care lipid testing market is also benefiting from increasing clinical emphasis on aggressive cardiovascular risk management and advances in digital healthcare infrastructure. Recent cardiovascular outcomes research continues to demonstrate the importance of sustained lipid control in reducing adverse cardiovascular events, creating greater demand for accessible and frequent lipid monitoring. Clinical findings presented from the VESALIUS-CV trial further reinforced the importance of intensive LDL cholesterol reduction strategies in high-risk populations, supporting broader adoption of point-of-care lipid testing in cardiology and diabetes care pathways. Simultaneously, manufacturers are increasingly incorporating lab-on-a-chip technologies, microfluidic platforms, Bluetooth connectivity, and telehealth integration capabilities into point-of-care analyzers. These innovations are enabling seamless data exchange across pharmacies, physician offices, cardiology practices, and remote monitoring platforms, accelerating the transition toward connected cardiovascular care ecosystems.
Point of Care Lipid Test Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Point of Care Lipid Test market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Abbott Laboratories, F. Hoffmann-La Roche Ltd, Nova Biomedical Corporation, SD Biosensor, Inc., Menarini Group, Sinocare Inc., EKF Diagnostics Holdings plc, VivaChek Biotech (Hangzhou) Co., Ltd., QuidelOrtho Corporation, Trinity Biotech plc. The Point of Care Lipid Test market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Point of Care Lipid Test industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Point of Care Lipid Test industry include- Abbott Laboratories, F. Hoffmann-La Roche Ltd, Nova Biomedical Corporation, SD Biosensor, Inc., Menarini Group, Sinocare Inc., EKF Diagnostics Holdings plc, VivaChek Biotech (Hangzhou) Co., Ltd., QuidelOrtho Corporation, Trinity Biotech plc. The Point of Care Lipid Test market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Point of Care Lipid Test Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Point of Care Lipid Test market remains one of the strongest-performing segments in the country.
The US Point of Care Lipid Test Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Point of Care Lipid Test market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Point of Care Lipid Test industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Point of Care Lipid Test markets
Canada's strong Point of Care Lipid Test sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Point of Care Lipid Test market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Point of Care Lipid Test Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Point of Care Lipid Test market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Point of Care Lipid Test population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Point of Care Lipid Test industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Point of Care Lipid Test market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Point of Care Lipid Test sales through 2034
France Point of Care Lipid Test companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Point of Care Lipid Test Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Point of Care Lipid Test distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Point of Care Lipid Test Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Point of Care Lipid Test market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Point of Care Lipid Test industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Point of Care Lipid Test industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Point of Care Lipid Test Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Point of Care Lipid Test market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Point of Care Lipid Test market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Point of Care Lipid Test Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Point of Care Lipid Test Market Segmentation
By Product Type
POC Testing Instruments / Analysers
Consumables
By Test Profile
Total Cholesterol (TC) Testing
Triglycerides (TG) Testing
High-Density Lipoprotein (HDL) Testing
Low-Density Lipoprotein (LDL) Testing
Complete Lipid Panels (Multi-parameter Testing)
By Application
Hyperlipidemia / Dyslipidemia Screening
Cardiovascular Risk Management
Diabetes Monitoring
By End User
Hospitals, ERs, and Critical Care Units
Physician Office Laboratories (POLs) and Diagnostic Clinics
Ambulatory Care Centers
Home Care and Personal Health Monitoring
Leading Companies in Point of Care Lipid Test Industry (2026)
Abbott Laboratories
F. Hoffmann-La Roche Ltd
Nova Biomedical Corporation
SD Biosensor, Inc.
Menarini Group
Sinocare Inc.
EKF Diagnostics Holdings plc
VivaChek Biotech (Hangzhou) Co., Ltd.
QuidelOrtho Corporation
Trinity Biotech plc
Countries Included
The Point of Care Lipid Test market report provides detailed analysis and outlook of Point of Care Lipid Test segments including By Product Type (POC Testing Instruments / Analysers, Consumables ), By Test Profile (Total Cholesterol (TC) Testing, Triglycerides (TG) Testing, High-Density Lipoprotein (HDL) Testing, Low-Density Lipoprotein (LDL) Testing, Complete Lipid Panels (Multi-parameter Testing)), By Application (Hyperlipidemia / Dyslipidemia Screening, Cardiovascular Risk Management, Diabetes Monitoring), By End User (Hospitals, ERs, and Critical Care Units, Physician Office Laboratories (POLs) and Diagnostic Clinics, Ambulatory Care Centers, Home Care and Personal Health Monitoring) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Point-of-Care Lipid Test Industry Overview
Preventive Cardiology, Decentralized Diagnostics, and Digital Health Integration Are Driving Market Expansion
The Point-of-Care (POC) Lipid Test industry is experiencing sustained growth as healthcare systems increasingly prioritize preventive cardiovascular care, rapid clinical decision-making, and decentralized diagnostic services. Rising rates of cardiovascular disease, diabetes, and metabolic disorders are accelerating demand for testing platforms capable of delivering immediate lipid profile results during a single patient encounter. Healthcare providers are increasingly adopting point-of-care lipid testing solutions to improve risk stratification, optimize treatment monitoring, and support value-based care models. At the same time, advances in microfluidics, digital connectivity, and multi-analyte testing technologies are transforming traditional lipid testing workflows into integrated diagnostic ecosystems.
Multi-Analyte Point-of-Care Platforms Are Enhancing Clinical Decision-Making
One of the most important trends shaping the point-of-care lipid testing market is the integration of lipid analysis with broader cardiometabolic testing capabilities. Healthcare providers increasingly prefer platforms capable of simultaneously measuring multiple biomarkers to improve workflow efficiency and patient management. Reflecting this trend, Abbott Laboratories continues to expand the clinical utilization of its Afinion™ 2 Analyzer, which enables rapid assessment of lipid profiles, HbA1c, and additional biomarkers within primary care, diabetes management, and cardiovascular care settings. The ability to generate actionable results during a single patient visit supports immediate therapeutic decision-making and reinforces the growing role of decentralized diagnostic testing in chronic disease management.
Intensive Lipid Management and Digital Connectivity Are Expanding Market Opportunities
The point-of-care lipid testing market is also benefiting from increasing clinical emphasis on aggressive cardiovascular risk management and advances in digital healthcare infrastructure. Recent cardiovascular outcomes research continues to demonstrate the importance of sustained lipid control in reducing adverse cardiovascular events, creating greater demand for accessible and frequent lipid monitoring. Clinical findings presented from the VESALIUS-CV trial further reinforced the importance of intensive LDL cholesterol reduction strategies in high-risk populations, supporting broader adoption of point-of-care lipid testing in cardiology and diabetes care pathways. Simultaneously, manufacturers are increasingly incorporating lab-on-a-chip technologies, microfluidic platforms, Bluetooth connectivity, and telehealth integration capabilities into point-of-care analyzers. These innovations are enabling seamless data exchange across pharmacies, physician offices, cardiology practices, and remote monitoring platforms, accelerating the transition toward connected cardiovascular care ecosystems.
Point of Care Lipid Test Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Point of Care Lipid Test market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Abbott Laboratories, F. Hoffmann-La Roche Ltd, Nova Biomedical Corporation, SD Biosensor, Inc., Menarini Group, Sinocare Inc., EKF Diagnostics Holdings plc, VivaChek Biotech (Hangzhou) Co., Ltd., QuidelOrtho Corporation, Trinity Biotech plc. The Point of Care Lipid Test market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Point of Care Lipid Test industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Point of Care Lipid Test Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Point of Care Lipid Test companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Point of Care Lipid Test markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Point of Care Lipid Test industry include- Abbott Laboratories, F. Hoffmann-La Roche Ltd, Nova Biomedical Corporation, SD Biosensor, Inc., Menarini Group, Sinocare Inc., EKF Diagnostics Holdings plc, VivaChek Biotech (Hangzhou) Co., Ltd., QuidelOrtho Corporation, Trinity Biotech plc. The Point of Care Lipid Test market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Point of Care Lipid Test Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Point of Care Lipid Test market remains one of the strongest-performing segments in the country.
The US Point of Care Lipid Test Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Point of Care Lipid Test market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Point of Care Lipid Test industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Point of Care Lipid Test markets
Canada's strong Point of Care Lipid Test sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Point of Care Lipid Test market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Point of Care Lipid Test Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Point of Care Lipid Test market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Point of Care Lipid Test population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Point of Care Lipid Test industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Point of Care Lipid Test market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Point of Care Lipid Test sales through 2034
France Point of Care Lipid Test companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Point of Care Lipid Test Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Point of Care Lipid Test distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Point of Care Lipid Test Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Point of Care Lipid Test market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Point of Care Lipid Test industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Point of Care Lipid Test industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Point of Care Lipid Test Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Point of Care Lipid Test market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Point of Care Lipid Test market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Point of Care Lipid Test Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Point of Care Lipid Test Market Segmentation
By Product Type
POC Testing Instruments / Analysers
Consumables
By Test Profile
Total Cholesterol (TC) Testing
Triglycerides (TG) Testing
High-Density Lipoprotein (HDL) Testing
Low-Density Lipoprotein (LDL) Testing
Complete Lipid Panels (Multi-parameter Testing)
By Application
Hyperlipidemia / Dyslipidemia Screening
Cardiovascular Risk Management
Diabetes Monitoring
By End User
Hospitals, ERs, and Critical Care Units
Physician Office Laboratories (POLs) and Diagnostic Clinics
Ambulatory Care Centers
Home Care and Personal Health Monitoring
Leading Companies in Point of Care Lipid Test Industry (2026)
Abbott Laboratories
F. Hoffmann-La Roche Ltd
Nova Biomedical Corporation
SD Biosensor, Inc.
Menarini Group
Sinocare Inc.
EKF Diagnostics Holdings plc
VivaChek Biotech (Hangzhou) Co., Ltd.
QuidelOrtho Corporation
Trinity Biotech plc
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Point of Care Lipid Test Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Point of Care Lipid Test Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL POINT OF CARE LIPID TEST MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Point of Care Lipid Test Markets in 2026
3.2. Global Historic and Forecast Point of Care Lipid Test Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Point of Care Lipid Test Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Point of Care Lipid Test Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Point of Care Lipid Test Value Chain
CHAPTER 4- POINT OF CARE LIPID TEST MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Point of Care Lipid Test Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- POINT OF CARE LIPID TEST MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
POC Testing Instruments / Analysers
Consumables
By Test Profile
Total Cholesterol (TC) Testing
Triglycerides (TG) Testing
High-Density Lipoprotein (HDL) Testing
Low-Density Lipoprotein (LDL) Testing
Complete Lipid Panels (Multi-parameter Testing)
By Application
Hyperlipidemia / Dyslipidemia Screening
Cardiovascular Risk Management
Diabetes Monitoring
By End User
Hospitals, ERs, and Critical Care Units
Physician Office Laboratories (POLs) and Diagnostic Clinics
Ambulatory Care Centers
Home Care and Personal Health Monitoring
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA POINT OF CARE LIPID TEST MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Point of Care Lipid Test Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Point of Care Lipid Test Market Trends and Growth Opportunities to 2034
7.5. North America Point of Care Lipid Test Market Size Outlook by Type
7.6. North America Point of Care Lipid Test Market Size Outlook by Application
7.7. North America Point of Care Lipid Test Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Point of Care Lipid Test Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Point of Care Lipid Test Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Point of Care Lipid Test Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Point of Care Lipid Test Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Point of Care Lipid Test Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Point of Care Lipid Test Companies
CHAPTER 8- EUROPE POINT OF CARE LIPID TEST MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Point of Care Lipid Test Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Point of Care Lipid Test Market Trends and Growth Opportunities to 2034
8.5. Europe Point of Care Lipid Test Market Size Outlook by Type
8.6. Europe Point of Care Lipid Test Market Size Outlook by Application
8.7. Europe Point of Care Lipid Test Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Point of Care Lipid Test Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Point of Care Lipid Test Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Point of Care Lipid Test Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Point of Care Lipid Test Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Point of Care Lipid Test Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Point of Care Lipid Test Companies
CHAPTER 9- ASIA PACIFIC POINT OF CARE LIPID TEST MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Point of Care Lipid Test Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Point of Care Lipid Test Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Point of Care Lipid Test Market Size Outlook by Type
9.6. Asia Pacific Point of Care Lipid Test Market Size Outlook by Application
9.7. Asia Pacific Point of Care Lipid Test Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Point of Care Lipid Test Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Point of Care Lipid Test Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Point of Care Lipid Test Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Point of Care Lipid Test Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Point of Care Lipid Test Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Point of Care Lipid Test Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA POINT OF CARE LIPID TEST MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Point of Care Lipid Test Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Point of Care Lipid Test Market Trends and Growth Opportunities to 2034
10.5. South and Central America Point of Care Lipid Test Market Size Outlook by Type
10.6. South and Central America Point of Care Lipid Test Market Size Outlook by Application
10.7. South and Central America Point of Care Lipid Test Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Point of Care Lipid Test Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Point of Care Lipid Test Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Point of Care Lipid Test Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Point of Care Lipid Test Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Point of Care Lipid Test Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Point of Care Lipid Test Companies
CHAPTER 11- MIDDLE EAST AND AFRICA POINT OF CARE LIPID TEST MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Point of Care Lipid Test Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Point of Care Lipid Test Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Point of Care Lipid Test Market Size Outlook by Type
11.6. Middle East and Africa Point of Care Lipid Test Market Size Outlook by Application
11.7. Middle East and Africa Point of Care Lipid Test Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Point of Care Lipid Test Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Point of Care Lipid Test Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Point of Care Lipid Test Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Point of Care Lipid Test Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Point of Care Lipid Test Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Point of Care Lipid Test Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Point of Care Lipid Test Industry
Abbott Laboratories
F. Hoffmann-La Roche Ltd
Nova Biomedical Corporation
SD Biosensor, Inc.
Menarini Group
Sinocare Inc.
EKF Diagnostics Holdings plc
VivaChek Biotech (Hangzhou) Co., Ltd.
QuidelOrtho Corporation
Trinity Biotech plc
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Point of Care Lipid Test Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Point of Care Lipid Test Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL POINT OF CARE LIPID TEST MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Point of Care Lipid Test Markets in 2026
3.2. Global Historic and Forecast Point of Care Lipid Test Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Point of Care Lipid Test Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Point of Care Lipid Test Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Point of Care Lipid Test Value Chain
CHAPTER 4- POINT OF CARE LIPID TEST MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Point of Care Lipid Test Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- POINT OF CARE LIPID TEST MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
POC Testing Instruments / Analysers
Consumables
By Test Profile
Total Cholesterol (TC) Testing
Triglycerides (TG) Testing
High-Density Lipoprotein (HDL) Testing
Low-Density Lipoprotein (LDL) Testing
Complete Lipid Panels (Multi-parameter Testing)
By Application
Hyperlipidemia / Dyslipidemia Screening
Cardiovascular Risk Management
Diabetes Monitoring
By End User
Hospitals, ERs, and Critical Care Units
Physician Office Laboratories (POLs) and Diagnostic Clinics
Ambulatory Care Centers
Home Care and Personal Health Monitoring
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA POINT OF CARE LIPID TEST MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Point of Care Lipid Test Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Point of Care Lipid Test Market Trends and Growth Opportunities to 2034
7.5. North America Point of Care Lipid Test Market Size Outlook by Type
7.6. North America Point of Care Lipid Test Market Size Outlook by Application
7.7. North America Point of Care Lipid Test Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Point of Care Lipid Test Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Point of Care Lipid Test Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Point of Care Lipid Test Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Point of Care Lipid Test Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Point of Care Lipid Test Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Point of Care Lipid Test Companies
CHAPTER 8- EUROPE POINT OF CARE LIPID TEST MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Point of Care Lipid Test Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Point of Care Lipid Test Market Trends and Growth Opportunities to 2034
8.5. Europe Point of Care Lipid Test Market Size Outlook by Type
8.6. Europe Point of Care Lipid Test Market Size Outlook by Application
8.7. Europe Point of Care Lipid Test Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Point of Care Lipid Test Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Point of Care Lipid Test Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Point of Care Lipid Test Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Point of Care Lipid Test Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Point of Care Lipid Test Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Point of Care Lipid Test Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Point of Care Lipid Test Companies
CHAPTER 9- ASIA PACIFIC POINT OF CARE LIPID TEST MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Point of Care Lipid Test Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Point of Care Lipid Test Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Point of Care Lipid Test Market Size Outlook by Type
9.6. Asia Pacific Point of Care Lipid Test Market Size Outlook by Application
9.7. Asia Pacific Point of Care Lipid Test Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Point of Care Lipid Test Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Point of Care Lipid Test Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Point of Care Lipid Test Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Point of Care Lipid Test Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Point of Care Lipid Test Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Point of Care Lipid Test Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Point of Care Lipid Test Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA POINT OF CARE LIPID TEST MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Point of Care Lipid Test Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Point of Care Lipid Test Market Trends and Growth Opportunities to 2034
10.5. South and Central America Point of Care Lipid Test Market Size Outlook by Type
10.6. South and Central America Point of Care Lipid Test Market Size Outlook by Application
10.7. South and Central America Point of Care Lipid Test Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Point of Care Lipid Test Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Point of Care Lipid Test Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Point of Care Lipid Test Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Point of Care Lipid Test Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Point of Care Lipid Test Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Point of Care Lipid Test Companies
CHAPTER 11- MIDDLE EAST AND AFRICA POINT OF CARE LIPID TEST MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Point of Care Lipid Test Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Point of Care Lipid Test Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Point of Care Lipid Test Market Size Outlook by Type
11.6. Middle East and Africa Point of Care Lipid Test Market Size Outlook by Application
11.7. Middle East and Africa Point of Care Lipid Test Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Point of Care Lipid Test Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Point of Care Lipid Test Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Point of Care Lipid Test Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Point of Care Lipid Test Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Point of Care Lipid Test Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Point of Care Lipid Test Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Point of Care Lipid Test Industry
Abbott Laboratories
F. Hoffmann-La Roche Ltd
Nova Biomedical Corporation
SD Biosensor, Inc.
Menarini Group
Sinocare Inc.
EKF Diagnostics Holdings plc
VivaChek Biotech (Hangzhou) Co., Ltd.
QuidelOrtho Corporation
Trinity Biotech plc
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
